published meta-analysis   sensitivity analysis   studies

standard of care in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsJamaati, 2021 (REV) 0.84 [0.27; 2.65] 0.84[0.27; 2.65]Jamaati, 2021 (REV)10%50NAnot evaluable deathsdetailed resultsCODEX (Tomazini), 2020 (REV) 1.03 [0.76; 1.39] DEXA-COVID19, 2020 (REV) 0.50 [0.05; 4.72] Jamaati, 2021 (REV) 0.84 [0.27; 2.65] RECOVERY dexamethasone, 2020 (REV) 1.20 [1.08; 1.34] 1.18[1.07; 1.30]CODEX (Tomazini), 2020 (REV), DEXA-COVID19, 2020 (REV), Jamaati, 2021 (REV), RECOVERY dexamethasone, 2020 (REV)40%6,793moderatenot evaluable clinical deteriorationdetailed resultsCODEX (Tomazini), 2020 (REV) 1.52 [0.98; 2.34] 1.52[0.98; 2.34]CODEX (Tomazini), 2020 (REV)10%299NAnot evaluable death or ventilationdetailed resultsRECOVERY dexamethasone, 2020 (REV) 1.09 [0.99; 1.19] 1.09[0.99; 1.19]RECOVERY dexamethasone, 2020 (REV)10%5,418NAnot evaluable hospital dischargedetailed resultsRECOVERY dexamethasone, 2020 (REV) 0.91 [0.85; 0.97] 0.91[0.85; 0.97]RECOVERY dexamethasone, 2020 (REV)10%6,425NAnot evaluable mechanical ventilationdetailed resultsJamaati, 2021 (REV) 0.73 [0.24; 2.21] RECOVERY dexamethasone, 2020 (REV) 1.30 [1.05; 1.61] 1.27[1.01; 1.59]Jamaati, 2021 (REV), RECOVERY dexamethasone, 2020 (REV)21%5,468moderatenot evaluable radiologic improvement (14-day)detailed resultsJamaati, 2021 (REV) 0.20 [0.05; 0.87] 0.20[0.05; 0.87]Jamaati, 2021 (REV)10%50NAnot evaluable serious adverse eventsdetailed resultsCODEX (Tomazini), 2020 (REV) 1.89 [0.62; 5.78] 1.89[0.62; 5.78]CODEX (Tomazini), 2020 (REV)10%299NAnot evaluable0.05.01.0relative treatment effectwww.metaEvidence.org2024-09-27 18:06 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 651 - roots T: 651